Stryker Pre-Tax Profit Margin 2010-2024 | SYK
Current and historical pre-tax profit margin for Stryker (SYK) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Stryker pre-tax profit margin for the three months ending September 30, 2024 was .
| Stryker Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $21.97B | $4.19B | 19.07% |
| 2024-06-30 | $21.39B | $4.02B | 18.78% |
| 2024-03-31 | $20.96B | $3.92B | 18.69% |
| 2023-12-31 | $20.50B | $3.67B | 17.92% |
| 2023-09-30 | $19.89B | $3.21B | 16.13% |
| 2023-06-30 | $19.46B | $3.16B | 16.22% |
| 2023-03-31 | $18.95B | $2.98B | 15.70% |
| 2022-12-31 | $18.45B | $2.68B | 14.54% |
| 2022-09-30 | $17.95B | $2.68B | 14.93% |
| 2022-06-30 | $17.63B | $2.36B | 13.38% |
| 2022-03-31 | $17.43B | $2.30B | 13.20% |
| 2021-12-31 | $17.11B | $2.28B | 13.33% |
| 2021-09-30 | $16.67B | $2.20B | 13.17% |
| 2021-06-30 | $16.25B | $2.48B | 15.27% |
| 2021-03-31 | $14.72B | $1.73B | 11.76% |
| 2020-12-31 | $14.35B | $1.95B | 13.62% |
| 2020-09-30 | $14.22B | $2.22B | 15.60% |
| 2020-06-30 | $14.07B | $2.02B | 14.36% |
| 2020-03-31 | $14.96B | $2.67B | 17.87% |
| 2019-12-31 | $14.88B | $2.56B | 17.21% |
| 2019-09-30 | $14.55B | $2.28B | 15.69% |
| 2019-06-30 | $14.20B | $2.24B | 15.74% |
| 2019-03-31 | $13.88B | $2.29B | 16.53% |
| 2018-12-31 | $13.60B | $2.36B | 17.32% |
| 2018-09-30 | $13.28B | $2.35B | 17.69% |
| 2018-06-30 | $13.04B | $2.29B | 17.52% |
| 2018-03-31 | $12.73B | $2.11B | 16.54% |
| 2017-12-31 | $12.44B | $2.06B | 16.58% |
| 2017-09-30 | $12.13B | $2.00B | 16.50% |
| 2017-06-30 | $11.96B | $1.95B | 16.31% |
| 2017-03-31 | $11.79B | $1.94B | 16.45% |
| 2016-12-31 | $11.33B | $1.92B | 16.96% |
| 2016-09-30 | $10.88B | $1.95B | 17.87% |
| 2016-06-30 | $10.47B | $1.87B | 17.87% |
| 2016-03-31 | $10.06B | $1.84B | 18.28% |
| 2015-12-31 | $9.95B | $1.74B | 17.44% |
| 2015-09-30 | $9.85B | $1.58B | 16.08% |
| 2015-06-30 | $9.82B | $1.66B | 16.95% |
| 2015-03-31 | $9.75B | $1.43B | 14.67% |
| 2014-12-31 | $9.68B | $1.16B | 11.99% |
| 2014-09-30 | $9.53B | $1.13B | 11.86% |
| 2014-06-30 | $9.29B | $0.84B | 9.07% |
| 2014-03-31 | $9.14B | $0.94B | 10.33% |
| 2013-12-31 | $9.02B | $1.21B | 13.44% |
| 2013-09-30 | $8.89B | $1.14B | 12.81% |
| 2013-06-30 | $8.79B | $1.45B | 16.45% |
| 2013-03-31 | $8.69B | $1.61B | 18.56% |
| 2012-12-31 | $8.66B | $1.71B | 19.70% |
| 2012-09-30 | $8.53B | $1.78B | 20.86% |
| 2012-06-30 | $8.51B | $1.77B | 20.76% |
| 2012-03-31 | $8.45B | $1.74B | 20.62% |
| 2011-12-31 | $8.31B | $1.69B | 20.30% |
| 2011-09-30 | $8.09B | $1.63B | 20.18% |
| 2011-06-30 | $7.82B | $1.66B | 21.26% |
| 2011-03-31 | $7.54B | $1.70B | 22.49% |
| 2010-12-31 | $7.32B | $1.73B | 23.63% |
| 2010-09-30 | $7.16B | $1.87B | 26.18% |
| 2010-06-30 | $7.04B | $1.73B | 24.50% |
| 2010-03-31 | $6.92B | $1.68B | 24.32% |
| 2009-12-31 | $6.72B | $1.62B | 24.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $148.171B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.157B | 25.91 |
| Boston Scientific (BSX) | United States | $133.131B | 38.28 |
| EssilorLuxottica (ESLOY) | France | $113.461B | 0.00 |
| Medtronic (MDT) | Ireland | $109.010B | 16.19 |
| Haleon (HLN) | United Kingdom | $42.913B | 27.88 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.122B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.701B | 19.56 |
| ResMed (RMD) | United States | $34.955B | 28.72 |
| Terumo (TRUMY) | Japan | $29.203B | 41.24 |
| Koninklijke Philips (PHG) | Netherlands | $24.410B | 18.68 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.087B | 14.06 |
| Insulet (PODD) | United States | $18.377B | 73.18 |
| Baxter (BAX) | United States | $16.604B | 10.80 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.153B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.468B | 37.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.977B | 30.51 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.523B | 12.83 |
| TG Therapeutics (TGTX) | United States | $4.720B | 0.00 |
| Haemonetics (HAE) | United States | $4.260B | 20.79 |
| ICU Medical (ICUI) | United States | $4.155B | 39.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.074B | 20.26 |
| Perrigo (PRGO) | Ireland | $3.716B | 10.94 |
| Envista Holdings (NVST) | United States | $3.487B | 25.97 |
| Neogen (NEOG) | United States | $3.270B | 37.72 |
| Agios Pharmaceuticals (AGIO) | United States | $3.103B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.789B | 17.89 |
| QuidelOrtho (QDEL) | United States | $2.595B | 16.70 |
| Warby Parker (WRBY) | United States | $2.344B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $2.332B | 56.69 |
| Green Thumb Industries (GTBIF) | United States | $1.964B | 34.37 |
| AtriCure (ATRC) | United States | $1.772B | 0.00 |
| InMode (INMD) | Israel | $1.487B | 8.94 |
| Curaleaf Holdings (CURLF) | Canada | $1.348B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.311B | 9.37 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.168B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.957B | 7.48 |
| CeriBell (CBLL) | United States | $0.916B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.888B | 29.68 |
| Capricor Therapeutics (CAPR) | United States | $0.839B | 0.00 |
| Evolus (EOLS) | United States | $0.785B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.608B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.596B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.596B | 26.47 |
| Surmodics (SRDX) | United States | $0.559B | 0.00 |
| Quanterix (QTRX) | United States | $0.424B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.404B | 0.00 |
| Valneva SE (VALN) | France | $0.370B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.63 |
| Omeros (OMER) | United States | $0.349B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.335B | 31.89 |
| Biote (BTMD) | United States | $0.330B | 7.25 |
| Sanara MedTech (SMTI) | United States | $0.323B | 0.00 |
| Cerus (CERS) | United States | $0.312B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.288B | 19.30 |
| Zynex (ZYXI) | United States | $0.249B | 52.13 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.15 |
| MacroGenics (MGNX) | United States | $0.218B | 0.00 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| Sanuwave Health (SNWV) | United States | $0.195B | 2.74 |
| Jin Medical (ZJYL) | China | $0.188B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.162B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 96.70 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 17.98 |
| TriSalus Life Sciences (TLSI) | United States | $0.126B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 10.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.00 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.082B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.080B | 41.50 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.066B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| Exagen (XGN) | United States | $0.062B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.026B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.17 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |